Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
- PMID: 33919917
- PMCID: PMC8070945
- DOI: 10.3390/cancers13081882
Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
Abstract
In cancer cells, a vital cellular process during metastasis is the transformation of epithelial cells towards motile mesenchymal cells called the epithelial to mesenchymal transition (EMT). The cytoskeleton is an active network of three intracellular filaments: actin cytoskeleton, microtubules, and intermediate filaments. These filaments play a central role in the structural design and cell behavior and are necessary for EMT. During EMT, epithelial cells undergo a cellular transformation as manifested by cell elongation, migration, and invasion, coordinated by actin cytoskeleton reorganization. The actin cytoskeleton is an extremely dynamic structure, controlled by a balance of assembly and disassembly of actin filaments. Actin-binding proteins regulate the process of actin polymerization and depolymerization. Microtubule reorganization also plays an important role in cell migration and polarization. Intermediate filaments are rearranged, switching to a vimentin-rich network, and this protein is used as a marker for a mesenchymal cell. Hence, targeting EMT by regulating the activities of their key components may be a potential solution to metastasis. This review summarizes the research done on the physiological functions of the cytoskeleton, its role in the EMT process, and its effect on multidrug-resistant (MDR) cancer cells-highlight some future perspectives in cancer therapy by targeting cytoskeleton.
Keywords: actin cytoskeleton; epithelial to mesenchymal transition; metastasis; multidrug resistance.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070945/bin/cancers-13-01882-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070945/bin/cancers-13-01882-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070945/bin/cancers-13-01882-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8070945/bin/cancers-13-01882-g004.gif)
Similar articles
-
Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression.Biomed Rep. 2015 Sep;3(5):603-610. doi: 10.3892/br.2015.494. Epub 2015 Jul 27. Biomed Rep. 2015. PMID: 26405532 Free PMC article.
-
Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells.Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):418-429. doi: 10.1016/j.bbamcr.2018.10.003. Epub 2018 Oct 5. Biochim Biophys Acta Mol Cell Res. 2019. PMID: 30296500
-
The roles and regulation of the actin cytoskeleton, intermediate filaments and microtubules in smooth muscle cell migration.Respir Res. 2017 Apr 8;18(1):54. doi: 10.1186/s12931-017-0544-7. Respir Res. 2017. PMID: 28390425 Free PMC article. Review.
-
Dissecting the contribution of actin and vimentin intermediate filaments to mechanical phenotype of suspended cells using high-throughput deformability measurements and computational modeling.J Biomech. 2014 Aug 22;47(11):2598-605. doi: 10.1016/j.jbiomech.2014.05.020. Epub 2014 Jun 6. J Biomech. 2014. PMID: 24952458
-
Cytoskeletal signaling in TGFβ-induced epithelial-mesenchymal transition.Cytoskeleton (Hoboken). 2015 Nov;72(11):557-69. doi: 10.1002/cm.21263. Epub 2015 Dec 9. Cytoskeleton (Hoboken). 2015. PMID: 26543012 Review.
Cited by
-
Targeting heme degradation pathway augments prostate cancer cell sensitivity to docetaxel-induced apoptosis and attenuates migration.Front Oncol. 2024 Jul 18;14:1431362. doi: 10.3389/fonc.2024.1431362. eCollection 2024. Front Oncol. 2024. PMID: 39091910 Free PMC article.
-
Enhanced Migration of Fuchs Corneal Endothelial Cells by Rho Kinase Inhibition: A Novel Ex Vivo Descemet's Stripping Only Model.Cells. 2024 Jul 19;13(14):1218. doi: 10.3390/cells13141218. Cells. 2024. PMID: 39056800 Free PMC article.
-
Microphysiological systems as models for immunologically 'cold' tumors.Front Cell Dev Biol. 2024 Apr 22;12:1389012. doi: 10.3389/fcell.2024.1389012. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38711620 Free PMC article. Review.
-
ISG12a promotes immunotherapy of HBV-associated hepatocellular carcinoma through blocking TRIM21/AKT/β-catenin/PD-L1 axis.iScience. 2024 Mar 19;27(4):109533. doi: 10.1016/j.isci.2024.109533. eCollection 2024 Apr 19. iScience. 2024. PMID: 38591006 Free PMC article.
-
Interaction of vascular endothelial cells with hydrophilic fullerene nanoarchitectured structures in 2D and 3D environments.Sci Technol Adv Mater. 2024 Feb 13;25(1):2315014. doi: 10.1080/14686996.2024.2315014. eCollection 2024. Sci Technol Adv Mater. 2024. PMID: 38419801 Free PMC article.
References
-
- Dai X., Ahn K.S., Wang L.Z., Kim C., Deivasigamni A., Arfuso F., Um J.Y., Kumar A.P., Chang Y.C., Kumar D., et al. Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Mol. Cancer. 2016;15:2966–2976. doi: 10.1158/1535-7163.MCT-16-0391. - DOI - PubMed
-
- Loo S.Y., Hirpara J.L., Pandey V., Tan T.Z., Yap C.T., Lobie P.E., Thiery J.P., Goh B.C., Pervaiz S., Clement M.V., et al. Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma. Antioxid Redox Signal. 2016;25:283–299. doi: 10.1089/ars.2015.6524. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources